"You can say this past decade was the decade of emergence of FMT into clinical practice," says Alexander Khoruts, medical director of the University of Minnesota"s Microbiota Therapeutics Program, and a pioneer in the FMT field. "Now we"re entering a new chapter that is a bit more serious in terms of product development. This [FMT] essentially was just a chapter in what"s probably going to be a story that will just continue this whole frontier of medical therapeutics."